KidneYou - Innovative Digital Therapy
Phase NA Completed
210 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Prospective Decision Impact Trial of KidneyIntelX
Active not recruiting
2,000 enrolled
BioFabry
Withdrawn
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
Phase 1 Completed
33 enrolled
TOP
Completed
761 enrolled 17 charts
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Phase 1 Completed
28 enrolled